Delivery Order 75D30120D07984-75D30120F00001
Award Date 7/30/20
Potential Completion Date 11/19/20
Potential Value $14M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Secaucus, NJ 07094, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
6
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...
- This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
- The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
- The Centers for Disease Control and Prevention (CDC) awarded a $16,500 purchase order to Quest Diagnostics Incorporated for deidentified Quest serum aliquots. Quest Diagnostics will deliver the aliquots to the CDC location in Halethorpe, Maryland by September 28, 2023 under the firm fixed price contract that began on September 1, 2023. As one of the largest clinical laboratories and medical testing companies in the United States, Quest Diagnostics will utilize its extensive experience and...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Quest Diagnostics Incorporated, a provider of diagnostic information services, for a "Test Surge and Data Sharing" program. The $493,118 contract has a period of performance through September 2025 and is a time and materials type contract. This IDIQ vehicle allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an...
- This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
- This is a $93,600 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a leading provider of clinical laboratory services. The contract is for the delivery of de-identified nasopharyngeal specimens, with a period of performance through August 13, 2026. This award does not have a set-aside designation. Quest Diagnostics has a long history of supporting federal agencies, including providing lab services for the CDC's...
- The Centers for Disease Control and Prevention (CDC) awarded a $1.249 million firm fixed price delivery order contract to Laboratory Corporation of America Holdings (LabCorp) for surge serology testing. Under the contract, LabCorp will provide serology testing services to the CDC in Burlington, North Carolina through December 2020 to support the agency's COVID-19 response efforts. No subcontractors or set aside designations were identified. The CDC is a component of the U.S. Department of Health...
- The Centers for Disease Control and Prevention (CDC) awarded a $8,587,890.00 firm fixed price definitive contract to Quest Diagnostics Nichols Institute, doing business as Quest Diagnostics, for genomic sequencing services. The contract supports the CDC's disease prevention and health promotion efforts through genomic surveillance of viruses like COVID-19. This contract does not have a set-aside designation. Quest Diagnostics Nichols Institute, a subsidiary of the parent company Quest...
- This is a $6,631,042.24 Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Quest Diagnostics Incorporated by the Centers for Disease Control and Prevention (CDC) to provide test surge and data sharing services. The contract has an ultimate completion date of September 26, 2029. This IDIQ contract is part of the broader "Test Surge and Data Sharing Multiple Award IDIQ" and does not have a set-aside designation. Under this contract, Quest Diagnostics will provide a...